Arvenin I is primarily studied for its potential neuroprotective properties. It has shown activity in modulating neuronal ion channels, particularly calcium channels, which play a key role in neurotransmitter release and neuronal excitability. This makes it a compound of interest in the development of treatments for neurological disorders such as epilepsy, chronic pain, and neurodegenerative diseases. Due to its specificity in binding to certain voltage-gated calcium channel subtypes, Arvenin I serves as a valuable tool in neuroscience research for dissecting channel function and synaptic transmission mechanisms. Its application extends to pharmacological studies aiming to design more selective and effective neuroactive drugs.